Latest Market Positioning News

Hawsons Iron Ltd has declared a JORC-compliant Probable Ore Reserve of 2.3 billion tonnes and completed a positive Pre-Feasibility Study supporting a 26-year, 12Mtpa magnetite concentrate project in New South Wales.

Epiminder Limited has settled a $15.77 million tax liability with the ATO related to historical R&D claims, freeing up $4.23 million from IPO proceeds for working capital.

Artemis Resources confirms a significant new gold discovery at Titan East with a wide 19m intersection at 1.6g/t Au, complementing earlier high-grade hits and prompting expanded drilling plans.

DataWorks Group signals a turning point with its strongest quarterly operating cash flow since refocusing on its core RegTech business, driven by key contracts in Australia and Ontario.

Treasury Wine Estates moderates its first-half fiscal 2026 outlook due to softer US and China markets, unveiling a major transformation program targeting $100 million in annual cost savings starting next year.

Harmoney Corp Limited reported a staggering 742% increase in Cash NPAT for FY25, driven by its new Stellare® 2.0 platform and operational efficiencies. The company reaffirmed its ambitious $12 million profit target for FY26 while unveiling a secured car loan product and securing a major bank debt facility.

Revolution Private Credit Income Trust has reported a solid $3.4 million operating profit for its inaugural half-year period, delivering a net return of 0.93% since listing and outperforming its benchmark. The Trust also declared a distribution of 0.35 cents per unit for October 2025.

Locate Technologies has completed its redomiciliation from Australia to New Zealand, establishing Locate NZ as the new parent company and appointing MUFG Pension & Market Services as its share registry provider.

ECS Botanics is strategically preparing for entry into the US medicinal cannabis market, leveraging its EU-GMP certification and proprietary genetics amid evolving regulatory landscapes.

Centrepoint Alliance forecasts a robust 13% increase in EBITDA for the first half of FY26, driven by strong adviser recruitment and platform scaling, cementing its position as the second-largest licensee in Australia.

DroneShield has landed a $49.6 million contract to supply handheld counterdrone systems to a European military customer, with deliveries and payments expected to complete by Q1 2026.

Immutep Limited reports robust progress in its pivotal Phase III TACTI-004 trial for advanced non-small cell lung cancer, with over 120 clinical sites activated across 27 countries including the US. Patient enrolment has reached 38% of the target, keeping key milestones on track.